- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medical Resources enjoys record income
Imaging services provider Medical Resources said it experiencedrecord financial results for its fourth quarter and year (end-December).Revenues for the year from continuing operations jumped 15% to$52 million, compared to $45.2 million in 1994. Earnings
Imaging services provider Medical Resources said it experiencedrecord financial results for its fourth quarter and year (end-December).Revenues for the year from continuing operations jumped 15% to$52 million, compared to $45.2 million in 1994. Earnings leapedto $4.1 million from a net loss of $1.1 million in 1994.
For the fourth quarter of 1995, the Clifton, NJ, company hadnet income of $1.2 million, a company record, on sales from continuingoperations of $13.7 million. In 1994, Medical Resources postednet income of $1 million on revenues of $11.7 million.
The company also announced that it has raised $6.5 millionin debentures that are convertible into common stock at $6 a share.Co-president and CFO Ronald Adamson said the proceeds from theoffering would be used to fund acquisitions, which Medical Resourceshas pursued aggressively (SCAN 11/8/95).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
